Literature DB >> 15451380

Enhanced visuomotor associative learning following stimulation of alpha 2A-adrenoceptors in the ventral prefrontal cortex in monkeys.

Min Wang1, Zong-Xiang Tang, Bao-Ming Li.   

Abstract

The present study investigated the effect of locally infused guanfacine, an alpha2A-adrenergic agonist, into the ventral prefrontal cortex (PFv) on visuomotor associative learning. Two monkeys were well trained on a two-problem visuomotor associative task: the monkeys performed movement A if presented with a circle pattern, or movement B if presented with a triangle pattern. For learning of new visuomotor associations, the monkeys were presented with a new set of four patterns in each and every daily session, two of which instructed movement A and the other two movement B. Bilaterally infused guanfacine (2.5 microg/microl; 3 microl on each side) improved the monkeys' ability to learn new visuomotor associations: trials and errors to learning criterion of 90% correct decreased significantly. The monkeys showed an enhanced capability to use win-stay/lose-shift strategy on 'repeat trials' and change-stay/change-shift strategy on 'change trials.' The present results indicate that alpha2A-adrenoceptor in the PFv is involved in regulating visuomotor associative learning.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451380     DOI: 10.1016/j.brainres.2004.07.062

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

Review 1.  The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.

Authors:  Amy F T Arnsten
Journal:  Expert Rev Neurother       Date:  2010-10       Impact factor: 4.618

Review 2.  Some recent advances in basic neuroscience research in China.

Authors:  Mu-ming Poo; Aike Guo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

Review 3.  Prefrontal cortical α2A-adrenoceptors and a possible primate model of attention deficit and hyperactivity disorder.

Authors:  Chao-Lin Ma; Xuan Sun; Fei Luo; Bao-Ming Li
Journal:  Neurosci Bull       Date:  2015-03-31       Impact factor: 5.203

Review 4.  Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders.

Authors:  Nao J Gamo; Amy F T Arnsten
Journal:  Behav Neurosci       Date:  2011-06       Impact factor: 1.912

Review 5.  Catecholamine influences on dorsolateral prefrontal cortical networks.

Authors:  Amy F T Arnsten
Journal:  Biol Psychiatry       Date:  2011-04-13       Impact factor: 13.382

Review 6.  Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.

Authors:  L Cinnamon Bidwell; Rachel E Dew; Scott H Kollins
Journal:  Curr Psychiatry Rep       Date:  2010-10       Impact factor: 5.285

Review 7.  α2-Adrenoceptors are targets for antipsychotic drugs.

Authors:  Jan Brosda; Florian Jantschak; Heinz H Pertz
Journal:  Psychopharmacology (Berl)       Date:  2014-02-02       Impact factor: 4.530

8.  Guanfacine modulates the emotional biasing of amygdala-prefrontal connectivity for cognitive control.

Authors:  Kurt P Schulz; Suzanne M Clerkin; Jeffrey H Newcorn; Jeffrey M Halperin; Jin Fan
Journal:  Eur Neuropsychopharmacol       Date:  2014-07-11       Impact factor: 4.600

Review 9.  Cognitive enhancement as a pharmacotherapy target for stimulant addiction.

Authors:  Mehmet Sofuoglu
Journal:  Addiction       Date:  2010-01       Impact factor: 6.526

Review 10.  Ameliorating prefrontal cortical dysfunction in mental illness: inhibition of phosphotidyl inositol-protein kinase C signaling.

Authors:  A F T Arnsten
Journal:  Psychopharmacology (Berl)       Date:  2008-08-22       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.